Speed diet: Women using ADD drugs to get thin Adderall spurs rapid weight loss. WebMD provides common contraindications for Adderall Oral. Adderall contraindications. Seizures, Loss of Appetite, Weight Loss. Average Weight Loss With AdderallAdderall Weight Loss Results
Adderall causing rapid weight loss - ADD Forums. Quote. Originally Posted by Jax. I started taking adderall 1. I've dropped from a healthy 1. I rarely feel hungry, but I always know I am. I find it difficult to force myself to eat though. It's to the point where eating makes me feel disgusted. It's interesting to deal with, but keeping snacks on hand definitely helps. Personally, I'm reaching the point where I feel I should take vitamins just to make up for the lack of nutrients in my diet. The appetite thing is hard for me because I have always felt about food the way you do, and it is typical for me to skip breakfast, have a big lunch(usually subway during the work week), and not feel hungry the rest of the day/night. Any other fast- food type places like Mc. Donald's, BK, ANY of them but especially the greasy and over- processed stuff gives me stomach aches and makes me feel sick for hours after eating the food so I quit getting it. Not many things appeal to my appetite, but I do go through periods around my time of the month where I can't get enough Chinese/Fried food. I eat the most and my usual eating habits go straight out the window. It's probably also what's kept me alive. To the OP: I have noticed with me, and believe it is the same for most others, if you are able to eat right before bed. I mean a MEAL of some kind, and then go to sleep you are more likely to gain if it becomes a habit. In your case, if that applies to you, it may effectively slow the weight loss. Combined with a good breakfast before taking your meds in the AM and you may get back to your comfortable weight. I opted for IR over XR so that I can have a better chance of feeling hungry between doses since I already struggle with appetite issues and may also begin supplementing with Vitamins for those common times where I just can't find it in me to want to eat even if I don't take my meds for a whole day. I already began buying Carnation Instant Breakfast for extra nutrition when my diet has been poor/non- existent. Adderall XR - FDA prescribing information, side effects and uses. Attention Deficit Hyperactivity Disorder. Adderall XR. The symptoms must cause clinically significant impairment, e. The symptoms must not be better accounted for by another mental disorder. For the Inattentive Type, at least six of the following symptoms must have persisted for at least 6 months: lack of attention to details/careless mistakes; lack of sustained attention; poor listener; failure to follow through on tasks; poor organization; avoids tasks requiring sustained mental effort; loses things; easily distracted; forgetful. For the Hyperactive- Impulsive Type, at least six of the following symptoms must have persisted for at least 6 months: fidgeting/squirming; leaving seat; inappropriate running/climbing; difficulty with quiet activities; . The Combined Type requires both inattentive and hyperactive- impulsive criteria to be met. Special Diagnostic Considerations. Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use not only of medical but of special psychological, educational, and social resources. Learning may or may not be impaired. The diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presence of the required number of DSM- IV. Drug treatment may not be indicated for all patients with this syndrome. Stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. When remedial measures alone are insufficient, the decision to prescribe stimulant medication will depend upon the physician's assessment of the chronicity and severity of the child's symptoms. Long- Term Use. The effectiveness of Adderall XR for long- term use, i. Therefore, the physician who elects to use Adderall XR for extended periods should periodically re- evaluate the long- term usefulness of the drug for the individual patient. DOSAGE and ADMINISTRATIONDosing Considerations for all Patients. Individualize the dosage according to the therapeutic needs and response of the patient. Administer Adderall XR at the lowest effective dosage. Based on bioequivalence data, patients taking divided doses of immediate- release ADDERALL, (for example, twice daily), may be switched to Adderall XR at the same total daily dose taken once daily. Titrate at weekly intervals to appropriate efficacy and tolerability as indicated. Adderall XR capsules may be taken whole, or the capsule may be opened and the entire contents sprinkled on applesauce. If the patient is using the sprinkle administration method, the sprinkled applesauce should be consumed immediately; it should not be stored. Patients should take the applesauce with sprinkled beads in its entirety without chewing. The dose of a single capsule should not be divided. The contents of the entire capsule should be taken, and patients should not take anything less than one capsule per day. Adderall XR may be taken with or without food. Adderall XR should be given upon awakening. Afternoon doses should be avoided because of the potential for insomnia. Where possible, Adderall XR therapy should be interrupted occasionally to determine if there is a recurrence of behavioral symptoms sufficient to require continued therapy. Children. In children with ADHD who are 6- 1. When in the judgment of the clinician a lower initial dose is appropriate, patients may begin treatment with 5 mg once daily in the morning. The maximum recommended dose for children is 3. Adderall XR have not been studied in children. Adderall XR has not been studied in children under 6 years of age. Adolescents. The recommended starting dose for adolescents with ADHD who are 1. The dose may be increased to 2. ADHD symptoms are not adequately controlled. Adults. In adults with ADHD who are either starting treatment for the first time or switching from another medication, the recommended dose is 2. Dosage Forms and Strengths. Adderall XR 5 mg capsules: Clear/blue (imprinted Adderall XR 5 mg)Adderall XR 1. Blue/blue (imprinted Adderall XR 1. Adderall XR 1. 5 mg capsules: Blue/white (imprinted Adderall XR 1. Adderall XR 2. 0 mg capsules: Orange/orange (imprinted Adderall XR 2. Adderall XR 2. 5 mg capsules: Orange/white (imprinted Adderall XR 2. Adderall XR 3. 0 mg capsules: Natural/orange (imprinted Adderall XR 3. Contraindications. Adderall XR administration is contraindicated in patients with the following conditions: Advanced arteriosclerosis. Symptomatic cardiovascular disease. Moderate to severe hypertension. Hyperthyroidism. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products . Although some serious heart problems alone carry an increased risk of sudden death, stimulant products generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a stimulant drug . Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious cardiac problems. Adults with such abnormalities should also generally not be treated with stimulant drugs . While the mean changes alone would not be expected to have short- term consequences, all patients should be monitored for larger changes in heart rate and blood pressure. Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate, e. Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during stimulant treatment should undergo a prompt cardiac evaluation. Psychiatric Adverse Events. Pre- Existing Psychosis. Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with pre- existing psychotic disorder. Bipolar Illness. Particular care should be taken in using stimulants to treat ADHD patients with comorbid bipolar disorder because of concern for possible induction of mixed/manic episode in such patients. Prior to initiating treatment with a stimulant, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression. Emergence of New Psychotic or Manic Symptoms. Treatment- emergent psychotic or manic symptoms, e. If such symptoms occur, consideration should be given to a possible causal role of the stimulant, and discontinuation of treatment may be appropriate. In a pooled analysis of multiple short- term, placebo- controlled studies, such symptoms occurred in about 0. Aggression. Aggressive behavior or hostility is often observed in children and adolescents with ADHD, and has been reported in clinical trials and the postmarketing experience of some medications indicated for the treatment of ADHD. Although there is no systematic evidence that stimulants cause aggressive behavior or hostility, patients beginning treatment for ADHD should be monitored for the appearance of or worsening of aggressive behavior or hostility. Long- Term Suppression of Growth. Monitor growth in children during treatment with stimulants. Patients who are not growing or gaining weight as expected may need to have their treatment interrupted. Careful follow- up of weight and height in children ages 7 to 1. In a controlled trial of Adderall XR in adolescents, mean weight change from baseline within the initial 4 weeks of therapy was - 1. Higher doses were associated with greater weight loss within the initial 4 weeks of treatment. Chronic use of amphetamines can be expected to cause a similar suppression of growth. Seizures. There is some clinical evidence that stimulants may lower the convulsive threshold in patients with prior history of seizures, in patients with prior EEG abnormalities in the absence of seizures, and very rarely, in patients without a history of seizures and no prior EEG evidence of seizures. In the presence of seizures, Adderall XR should be discontinued. Peripheral Vasculopathy, including Raynaud's phenomenon. Stimulants, including Adderall XR, used to treat ADHD are associated with peripheral vasculopathy, including Raynaud's phenomenon. John's Wort . Amphetamines and amphetamine derivatives are known to be metabolized, to some degree, by cytochrome P4. D6 (CYP2. D6) and display minor inhibition of CYP2. D6 metabolism . The potential for a pharmacokinetic interaction exists with the co- administration of CYP2. D6 inhibitors which may increase the risk with increased exposure to Adderall XR. In these situations, consider an alternative non- serotonergic drug or an alternative drug that does not inhibit CYP2. D6 . Serotonin syndrome symptoms may include mental status changes (e. Concomitant use of Adderall XR with other serotonergic drugs or CYP2. D6 inhibitors should be used only if the potential benefit justifies the potential risk. If clinically warranted, consider initiating Adderall XR with lower doses, monitoring patients for the emergence of serotonin syndrome during drug initiation or titration, and informing patients of the increased risk for serotonin syndrome. Visual Disturbance. Difficulties with accommodation and blurring of vision have been reported with stimulant treatment. Tics. Amphetamines have been reported to exacerbate motor and phonic tics and Tourette's syndrome.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
August 2017
Categories |